Back to Search
KEITH TOKUHARA, M.D.
M.D.
Ophthalmology Physician
NPI: 1386822641Individual
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
A97863(CA)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
UNIVERSITY OF HAWAII JOHN A. BURNS SCHOOL OF MEDICINE
Class of 2005
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: a pilot study.
PMID 22081150·Cornea·2012
2-rct
A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results.
PMID 21915047·Cornea·2011
2-rct
Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture.
PMID 21584260·J Ophthalmol·2011
8-other
Subconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trial.
PMID 21955635·Cornea·2011
2-rct
The safety of using anti-VEGF: Is there strength in numbers? Curtis LH, Hammill BG, Schulman KA, Cousins SW (2010) Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. Arch Ophthalmol 128(10):1273-1279.
PMID 21210141·Graefes Arch Clin Exp Ophthalmol·2011
8-other
Bevacizumab and ocular wound healing after primary pterygium excision.
PMID 20977367·J Ocul Pharmacol Ther·2011
4-observational
Efficacy of intralesional bevacizumab injection in decreasing pterygium size.
PMID 20885313·Cornea·2011
8-other
Efficacy of topical bevacizumab for inhibiting growth of impending recurrent pterygium.
PMID 20021250·Curr Eye Res·2010
2-rct
Intravitreous bevacizumab injection: an experimental study in New Zealand white rabbits.
PMID 20625050·Arch Ophthalmol·2010
7-preclinical
Is monthly retreatment with intravitreal bevacizumab (Avastin) necessary in neovascular age-related macular degeneration?
PMID 20463798·Clin Ophthalmol·2010
8-other
Growth factor expression in ophthalmic pterygia and normal conjunctiva.
PMID 20198298·Int J Mol Med·2010
8-other
Preliminary results of subconjunctival bevacizumab in primary pterygium excision.
PMID 19887878·Ophthalmic Res·2010
2-rct
Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives (Review).
PMID 19288018·Int J Mol Med·2009
6-review
Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy.
PMID 19668504·Clin Ophthalmol·2007
8-other
Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
PMID 17700285·J Glaucoma·2007
5-case
Current concepts and techniques in pterygium treatment.
PMID 17568207·Curr Opin Ophthalmol·2007
6-review
Rebamipide, anti-gastric ulcer drug, up-regulates the induction of iNOS in proinflammatory cytokine-stimulated hepatocytes.
PMID 17936043·Nitric Oxide·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 35900 BOB HOPE DR STE 175
RANCHO MIRAGE, CA 92270 - Phone
- (760) 340-4700
Quick Facts
- NPI
- 1386822641
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 21
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile